NextCure, Inc. (NXTC)
6.88
+0.30
(+4.56%)
USD |
NASDAQ |
Oct 15, 16:00
7.09
+0.21
(+3.05%)
After-Hours: 20:00
NextCure Market Cap : 27.99M for Oct. 15, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 15, 2026 | 27.99M |
| October 14, 2026 | 26.77M |
| October 13, 2026 | 25.55M |
| October 12, 2026 | 27.02M |
| October 09, 2026 | 29.22M |
| October 08, 2026 | 27.59M |
| October 07, 2026 | 26.69M |
| October 06, 2026 | 23.13M |
| October 05, 2026 | 20.55M |
| October 02, 2026 | 20.71M |
| October 01, 2026 | 20.18M |
| September 30, 2026 | 20.39M |
| September 29, 2026 | 19.71M |
| September 28, 2026 | 20.67M |
| September 25, 2026 | 20.67M |
| September 24, 2026 | 21.48M |
| September 23, 2026 | 19.61M |
| September 22, 2026 | 21.08M |
| September 21, 2026 | 22.22M |
| September 18, 2026 | 24.90M |
| September 17, 2026 | 23.07M |
| September 16, 2026 | 24.54M |
| September 15, 2026 | 25.92M |
| September 14, 2026 | 27.02M |
| September 11, 2026 | 28.48M |
| Date | Value |
|---|---|
| September 10, 2026 | 29.74M |
| September 09, 2026 | 32.84M |
| September 08, 2026 | 34.26M |
| September 04, 2026 | 31.82M |
| September 03, 2026 | 31.90M |
| September 02, 2026 | 29.91M |
| September 01, 2026 | 27.67M |
| August 31, 2026 | 26.00M |
| August 28, 2026 | 24.78M |
| August 27, 2026 | 24.56M |
| August 26, 2026 | 23.72M |
| August 25, 2026 | 24.05M |
| August 24, 2026 | 23.97M |
| August 21, 2026 | 25.59M |
| August 20, 2026 | 25.43M |
| August 19, 2026 | 27.59M |
| August 18, 2026 | 27.06M |
| August 17, 2026 | 31.37M |
| August 14, 2026 | 33.41M |
| August 13, 2026 | 33.69M |
| August 12, 2026 | 33.24M |
| August 11, 2026 | 27.38M |
| August 10, 2026 | 27.83M |
| August 07, 2026 | 23.76M |
| August 06, 2026 | 22.75M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.256B |
| Oncolytics Biotech, Inc. | 68.25M |
| Sangamo Therapeutics, Inc. | 58.37M |
| Sarepta Therapeutics, Inc. | 1.879B |
| Anixa Biosciences, Inc. | 96.14M |
Market Cap Related Metrics
| Price to Book Value | 2.304 |
| Price | 6.88 |
| Earnings Yield | -153.9% |